How RWE can support drug development during COVID-19 and beyond
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...
This is part one of a three-part series on the essential qualities of claims data for life sciences research. Next up: the role of consistent data in producing reliable and reproducible results.